Gian Matteo Rigolin

36PUBLICATIONS
157CO-AUTHORS
Haematological tumoursLiquid biopsiesCardiology (incl. cardiovascular diseases)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (36)

|Sep 19, 2025
Clinical and transcriptomic characterization of patients with chronic lymphocytic leukemia harboring t(14;19): an ERIC study.

Andrea Visentin, Enrico Gaffo, Moritz Fürstenau

|Jun 25, 2025
Richter transformation in diffuse large B-cell lymphoma in patients with chronic lymphocytic leukemia receiving ibrutinib: risk factors and outcomes.

Sara Pepe, Candida Vitale, Diana Giannarelli

|Apr 24, 2025
ATM aberrations in chronic lymphocytic leukemia: del(11q) rather than ATM mutations is an adverse-prognostic biomarker.

Birna Thorvaldsdottir, Larry Mansouri, Lesley-Ann Sutton

|Mar 30, 2025
Upfront intensive treatment analysis of the Italian Cohort Study on FLT3-mutated AML patients (FLAM): The impact of a FLT3 inhibitor addition to standard chemotherapy in the real-life setting.

Jacopo Nanni, Irene Azzali, Cristina Papayannidis

|Oct 09, 2024
Outcomes and prognostic factors in 3306 patients with relapsed/refractory chronic lymphocytic leukemia treated with ibrutinib outside of clinical trials: A nationwide study.

Gian Matteo Rigolin, Pier Paolo Olimpieri, Valentina Summa

|Aug 10, 2024
Chronic Lymphocytic Leukemia: Prognostic Factors in the Era of Novel Drugs.

Antonio Urso, Enrica Antonia Martino, Antonio Cuneo

Pageof 6

Frequent Collaborators

10 joint publications

Francesca Romana Mauro

9 joint publications

Luca Laurenti

8 joint publications

Andrea Visentin

7 joint publications

Livio Trentin